Rivaroxaban plus aspirin for the prevention of ischaemic events in patients with cardiovascular disease: a cost-effectiveness study

Svenja Petersohn*, Xavier Pouwels, Bram Ramaekers, Arina ten Cate-Hoek, Manuela Joore

*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

52 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Rivaroxaban plus aspirin for the prevention of ischaemic events in patients with cardiovascular disease: a cost-effectiveness study'. Together they form a unique fingerprint.

Keyphrases

INIS

Pharmacology, Toxicology and Pharmaceutical Science